Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013


3rd Annual Advancing Clinical Research in Turkey, the Middle East & North Africa

18 Jun 2013 - 19 Jun 2013 - Istanbul, Turkey



Bookmark and Share


NextLevel Pharma’s “Advancing clinical research in Turkey, the Middle East and North Africa” will bring together the local regulators and ethics committees, alongside experienced investigators and study personnel as well as clinical trial experts from pharma and CROs. It will examine in detail, the key regulatory, clinical, outsourcing and environmental factors which impact the clinical trials. Particular and specific attention will be given to Turkey, Egypt, Saudi Arabia, the Gulf States, Jordan & Lebanon via separate, focused, streamed conference sessions.

 

Why Attend?

·         Gain vital local knowledge by hearing updates on the varied and changing clinical regulations

·         Meet regulators and KOLs from the region to maximise your regional networks

·         Adapt your tactics to train, motivate and retain the clinical teams and patients in these specific regions

·         Discover what is the most efficient operating model to maximise your recruitment potential in this exciting region

·         Hear case study presentations from experts active in Turkey, the Middle East and North Africa region, sharing their clinical experiences and lessons learned

·         Network and build the contacts & relationships you need at NextLevel Pharma’s very popular & entertaining networking dinner

 

Agenda request

To request the full agenda please follow the link: http://www.nextlevelpharma.com/events/request_agenda/3rd_annual_advancing_clinical_research_in_turkey_the_middle_east_north_africa

For Booking Information contact:

Erika Vavrovicova

 

Tel: +421 232 660 382

Fax: +421 2 3301 0331
Email:
erika@nextlevelpharma.com

Visit: www.nextlevelpharma.com



Further information
Scientific News
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Stem Cell Therapy Heals Injured Mouse Brain
A team of researchers has developed a therapeutic technique that dramatically increases the production of nerve cells in mice with stroke-induced brain damage.
Zika Vaccine Testing in Humans
The NAAID has initiated a clinical trail of a vaccine candidate for the prevention of the Zika virus infection.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!